• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Novartis

edit

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in each of these areas. In 2008, the GroupÂ’s continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 99,000 full-time-equivalent associates and operate in more than 140 countries around the world.

Milestones

edit

• 
  Novartis added Cris De Luca as Assoc. Director Research Computing. (1/10/07)
  Posted 2/20/11 at 11:08pm
• 
  Novartis acquired Corthera for $620M. (12/23/09)
  Posted 1/12/10 at 5:38am via novartis.com
• 
  Novartis — Foundation Medicine has inked a collaboration deal with Novartis AG to tailor Foundation’s genome-based tests to Novartis’ needs (1/4/11)
  Posted 1/5/11 at 6:45am via masshightech.com
• 
  Novartis — Foundation Medicine has inked a collaboration deal with Novartis AG to tailor Foundation’s genome-based tests to Novartis’ needs (1/4/11)
  Posted 1/5/11 at 6:43am via masshightech.com
• 
  Novartis — Foundation Medicine has inked a collaboration deal with Novartis AG to tailor Foundation’s genome-based tests to Novartis’ needs (1/4/11)
  Posted 1/5/11 at 6:41am via masshightech.com
• 
  Novartis — discontinuing late stage clinical trials for a drug candidate to treat lung cancer because the trial was unlikely to meet its endpoint. (11/11/10)
  Posted 11/16/10 at 4:35am via masshightech.com
• 
  Novartis — plans to expand its global headquarters in Cambridge by adding 400,000 square feet and hiring 300 workers over the next five years (10/27/10)
  Posted 10/28/10 at 6:45am via masshightech.com
• 
  Novartis — plans to expand its global headquarters in Cambridge by adding 400,000 square feet and hiring 300 workers over the next five years (10/27/10)
  Posted 10/27/10 at 7:33am via masshightech.com

Videos

Screenshots

edit

Above: Novartis
Uploaded: 1/12/10

Sources

1. Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III project relaxin for treatment of acute decompensated heart failure (novartis.com) [edit]
2. Novartis to add jobs, expand Cambridge site (masshightech.com) [edit]
3. Novartis to add jobs, expand Cambridge site (masshightech.com) [edit]
4. Novartis halts lung cancer trial (masshightech.com) [edit]
5. Foundation Medicine, Novartis team up on cancer diagnostics (masshightech.com) [edit]
6. Foundation Medicine, Novartis team up on cancer diagnostics (masshightech.com) [edit]
7. Foundation Medicine, Novartis team up on cancer diagnostics (masshightech.com) [edit]